GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » 3-Year EBITDA Growth Rate

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) 3-Year EBITDA Growth Rate : 26.30% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories 3-Year EBITDA Growth Rate?

Kraig Biocraft Laboratories's EBITDA per Share for the three months ended in Dec. 2023 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 26.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -11.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kraig Biocraft Laboratories was 30.70% per year. The lowest was -100.00% per year. And the median was -14.50% per year.


Competitive Comparison of Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate

For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate falls into.



Kraig Biocraft Laboratories 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Kraig Biocraft Laboratories  (OTCPK:KBLB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Kraig Biocraft Laboratories 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.
Executives
Jonathan Richard Rice officer: COO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson director, 10 percent owner, officer: CEO, CFO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Headlines

From GuruFocus

Kraig Biocraft Laboratories Receives $1.5 Million in Capital Funding

By GuruFocusNews GuruFocusNews 04-14-2022

USPTO Publishes Two Key Kraig Biocraft Laboratories Patent Applications

By GuruFocusNews GuruFocusNews 02-16-2022